Latest

  • Featured

    From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

    By Marcelo Corrales Compagnucci Extended Reality (XR) technologies like Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR), are revolutionizing healthcare. These tools, powered by artificial intelligence (AI), are enhancing how medical professionals work across…

    From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

  • Addiction

    Stephanie Tabashneck: An “Interpreter” Between Two Fields

    Stephanie Tabashneck, PsyD, JD, is a Senior Fellow in Law and Applied Neuroscience at the Petrie-Flom Center and Center for Law, Brain and Behavior (CLBB) at Massachusetts General Hospital/Harvard Medical School. A forensic psychologist and…

    Stephanie Tabashneck: An “Interpreter” Between Two Fields

  • Abortion

    Routing Back to Roe in Light of Adverse State Supreme Court Abortion Decisions

    By James G. Hodge, Jr. and Jennifer L. Piatt Surrounding the U.S. Supreme Court’s withdrawal of the longstanding constitutional right to abortion in Dobbs v. Jackson Women’s Health Organization on June 24, 2022, multiple state…

    Routing Back to Roe in Light of Adverse State Supreme Court Abortion Decisions

  • Abortion

    Two Years On From A “Landmark” Abortion Decision in Kenya

    Two years ago, the Kenyan High Court in Malindi decided PAK and Salim Mohammed v. Attorney General et al., affirming that the constitutional right to abortion is “fundamental.” Approximately 2,600 people lose their lives to…

    Two Years On From A “Landmark” Abortion Decision in Kenya

  • Health Law Policy

    Salus Populi: Training the Judiciary in the Social Drivers of Health

    By Elaine Marshall, Isabel Geisler, L. Virginia Martinez, Krystal Abbott, and Katherine Hazen Social drivers of health (SDOH), sometimes known as the social determinants of health, are factors in the social environment that shape individual…

    Salus Populi: Training the Judiciary in the Social Drivers of Health

  • Adithi Iyer

    Cell Therapies and their Legal Discontents

    In February, the news broke that the Food and Drug Administration (FDA) had approved a “first of its kind” new cancer therapy. Iovance’s AMTAGVITM, the subject of the approval, is a personalized immunotherapy for advanced…

    Cell Therapies and their Legal Discontents

  • Bobby Stroup

    Protecting Health Privacy is a Royal Pain

    Heightened Scrutiny of Your Royal Highness On Sunday, March 10, tabloids were in quite a frenzy when the British royal family published a photoshopped picture of Catherine, princess of Wales. The hubbub was extra hubbubbly, because…

    Protecting Health Privacy is a Royal Pain

  • Artificial Intelligence

    EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

    By Suzan Slijpen, Mauritz Kop & I. Glenn Cohen 1. Introduction: A Fragmented AI in Healthcare Regulatory Landscape In the past few years, we have witnessed a surge in artificial intelligence-related research and diagnostics in…

    EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

  • FDA

    Insurance Coverage for Psychedelic Therapy

    By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. For example, experts…

    Insurance Coverage for Psychedelic Therapy

  • FDA

    The FDA Backdoor to MDMA Rescheduling

    FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.

    The FDA Backdoor to MDMA Rescheduling

    Silver Spring, MD, USA - June 25, 2022: The U.S. Department of Health and Human Services (HHS), U.S. Public Health Service (USPHS) and FDA logos are seen at the FDA headquarters, the White Oak Campus.